Andrew Soteriou’s Post

View profile for Andrew Soteriou, graphic

Global CEO | Board Member, Investor & Advisor | Sustainable Growth & Impact Innovation | Biodiversity in Human & Economic Systems | Global RGM & Commercial Transformations | Speaker & Author: Smart Growth | 200HR Yogi

The FDA, in a move that’s as predictable as it is infuriating, has disgracefully chosen not to approve MDMA-assisted therapy for patients suffering from PTSD. Rather than embracing a treatment that could genuinely offer hope, they’ve decided to cling to the same failed strategies that have failed many (including veterans/ trauma victims in high crime locations) for over 25 years. By turning a blind eye to promising new therapies, the FDA has ignored the urgent need for real solutions. Today’s vote is nothing short of a disgrace, a betrayal of those who have already sacrificed so much. The decision demands further investigations into the treatment's safety and effectiveness, delaying potential relief for many veterans. At the root of this decision, as with the UK's stance on decriminalising marijuana, lies the protection of #pharmaceutical revenues. Big Pharma has historically opposed the legalisation and acceptance of alternative treatments that could threaten their market share. In the case of marijuana, #pharmaceutical and #alcohol companies have been known to #bankroll #opposition to its legalisation to protect their interests. #lobbyists Similarly, the hesitation to approve MDMA-assisted therapy may be influenced by the potential disruption it poses to the lucrative market for traditional PTSD medications and treatments. #protections #barriers #moats #headlocks

View profile for Elaine Brewer, graphic

Founder of Humble Warrior Wellness Center a 501(c)(3) nonprofit organization

The FDA, in a move that’s as predictable as it is infuriating, has disgracefully chosen not to approve MDMA-assisted therapy for veterans suffering from PTSD. Rather than embracing a treatment that could genuinely offer hope, they’ve decided to cling to the same failed strategies that have failed veterans for over 25 years. By turning a blind eye to promising new therapies, the FDA has ignored the urgent need for real solutions. Today’s vote is nothing short of a disgrace, a betrayal of those who have already sacrificed so much.

  • No alternative text description for this image

To view or add a comment, sign in

Explore topics